AKT1 and non-small cell lung carcinoma: Recent researches have demonstrated that the activation of the PI3K/AKT signaling pathway occurs in 90% of non-small cell lung cancer (NSCLC) cell lines, and the inhibition of this signaling cascade is not only important for induction of autophagic cell death but also provides insight for developing new treatments [25, 26].